Development & Regulatory Activities to De-risk & Support Your Fundraising Strategy
Scendea Authors:
Dr Dmitry Zamoryakhin, Meredith Manuel, Ellen Wilkinson, Erik Doevendans
Toronto Stock Exchange & TSX Venture Exchange Authors:
Omar Khafagy, CFA
Biotech companies, who are looking to secure investment to enable development of their medicinal products, must navigate a competitive funding landscape while optimizing their fundraising strategies. To de-risk and support fundraising strategies globally it’s imperative that product development and regulatory strategy are carefully considered and enacted upon.
Canada has established itself as a global hub for life sciences innovation, offering strong investor interest and access to deep capital markets. As such knowing how to navigate Canada’s life sciences sector can provide a competitive advantage when securing investment. This whitepaper provides insights into the current global investor environment for startups, highlights opportunities that may help to secure investment and outline the development data required for fundraising. Finally, we discuss key factors that may help drive successful capital raising in Canada’s life sciences sector…